⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALVO News
Alvotech Ordinary Shares
Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update
globenewswire.com
ALVO
Alvotech Investors Should Contact Block & Leviton to Find Out How They Might Recover Losses Through The Firm's Investigation
accessnewswire.com
ALVO
Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05
globenewswire.com
ALVO
Alvotech Provides Update on the Status of U.S. Biologics License Application for AVT05
globenewswire.com
ALVO
Alvotech birtir nýjar upplýsingar um stöðu umsóknar um markaðsleyfi fyrir AVT05 í Bandaríkjunum
globenewswire.com
ALVO
European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency
globenewswire.com
ALVO
European Marketing Application for AVT23, a Proposed Biosimilar to Xolair® (omalizumab), Accepted by the European Medicines Agency
globenewswire.com
ALVO